Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass

for
Ovarian Neoplasms
Location: Annandale VA, Panama City FL, Houston TX, Jackson TN,
Sponsor: Cleo Diagnostics Ltd

Sex: Female

Age: 18+

Code: NCT06566716

Recruiting

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

for
Surgery
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 45+

Code: NCT06312124

Recruiting

Study Looking at Biomarkers in Ovarian Cancer

for
Gynecologic Cancer
Location: Ottawa, Kingston, Toronto, Barrie, London
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT03419689

Recruiting

Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers

for
Diagnoses Disease
Location: Montreal
Sponsor: McGill University

Sex: Female

Age: 45 - 70+

Code: NCT04891029

Recruiting

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

for
Ovary Cancer
Location: Knoxville TN
Sponsor: University of Tennessee Graduate School of Medicine

Sex: Female

Age: 18+

Code: NCT06800105

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery

for
Salpingectomy, Colorectal Surgery
Location: Vancouver
Sponsor: University of British Columbia

Sex: Female

Age: 15 - 70+

Code: NCT05300711

Recruiting

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

for
Cancer, Ovarian, Chemotherapy Effect, Calorie Deficiency,
Location: Knoxville TN
Sponsor: L-Nutra Inc

Sex: Female

Age: 35 - 70

Code: NCT06376604

Recruiting

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

for
Cervical Cancer, Endometrial Cancer, Ovarian Epithelial Cancer
Location: Maywood IL
Sponsor: Bital Savir-Baruch

Sex: Female

Age: 18+

Code: NCT03349463

Recruiting

WellSpan-THRIVE Cancer QOL Study

for
Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative,
Location: Ephrata PA, Lebanon PA, York PA, Gettysburg PA,
Sponsor: WellSpan Health

Sex: All

Age: 18+

Code: NCT07433660

Recruiting

Survivors Uniting for Remote Guided Exercise

for
Cancer,
Location: Fort Collins CO
Sponsor: Colorado State University

Sex: All

Age: 18+

Code: NCT07290309

Recruiting

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

for
Ovarian Neoplasms
Location: Montreal
Sponsor: McGill University

Sex: Female

Age: 45+

Code: NCT02296307

Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency),
Location: New Haven CT, New York NY, Houston TX, Sacramento CA
Sponsor: Duke Street Bio Ltd

Sex: All

Age: 18+

Code: NCT06458712

Phase1, Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Providence RI, Philadelphia PA, Cleveland OH,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase1, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Boston MA, Burlington MA, Hartford CT, Springfield MA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase2, Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05985655

Phase1, Phase2, Recruiting

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

for
Platinum-Resistant Fallopian Tube Carcinoma,
Location: Pittsburgh PA
Sponsor: Ronald Buckanovich

Sex: Female

Age: 18+

Code: NCT05538091

Phase2, Recruiting

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

for
Fallopian Tube Carcinosarcoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT04919629

Phase2, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase2, Phase3, Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Hackensack NJ, Montreal, Hamilton, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

for
Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT03604315

Phase1, Recruiting